Keywords: knoll, high, hopes, its, obesity, drug, sibutramine

Knoll's High Hopes For Its Obesity Drug Sibutramine

Article | 15 January 1998

Print This

Knoll Pharmaceuticals, a division of Germany's BASF group, has greatconfidence in its new drug sibutramine for the management of obesity. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in